The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism

The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism. A need exists for a therapy that lowers parathyroid hormone (PTH) without increasing calcium x phosphorus in patients with secondary hyperparathyroidism. The calcimimetic AMG 073 increases...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Kidney international 2003-01, Vol.63 (1), p.248-254
Hauptverfasser:	Lindberg, Jill S., Moe, Sharon M., Goodman, William G., Coburn, Jack W., Sprague, Stuart M., Liu, Wei, Blaisdell, Peter W., Brenner, Robert M., Turner, Stewart A., Martin, Kevin J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences calcimimetic Calcitriol - administration & dosage Calcium - blood Calcium Channel Agonists - administration & dosage calcium x phosphorus calcium-sensing receptor Cinacalcet Hydrochloride Emergency and intensive care: renal failure. Dialysis management end-stage renal disease Female General and cellular metabolism. Vitamins Humans Hyperparathyroidism, Secondary - blood Hyperparathyroidism, Secondary - drug therapy Intensive care medicine Kidney Failure, Chronic - complications Kidney Failure, Chronic - therapy Male Medical sciences Middle Aged Naphthalenes - administration & dosage Naphthalenes - adverse effects parathyroid hormone Parathyroid Hormone - blood Pharmacology. Drug treatments Phosphorus - blood Renal Dialysis secondary hyperparathyroidism Titrimetry
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!